Developing New Demand Through Compact Equipment Development and Direct Sales to Testing Laboratories
First written in FY2017. 7 of 12 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Overseas sales amounted to ¥446.079 million, up 11.8% from the previous fiscal year, as compact models increased sales in Asian markets.」
Regarding new-demand development using compact models, sales increased 11.8% in Asian markets. The company showed concrete sales progress supporting expansion beyond large facilities. - FY2024WorsenedAnnual report
「In overseas markets, revenue fell substantially below the previous fiscal year's level due to the postponement of projects for China and South Korea and intensifying competition with other companies in various countries, resulting in revenue of ¥155,790 thousand, down 44.6% year on year.」
Overseas sales related to new-demand development, including compact and medium-sized models, fell 44.6% from the previous fiscal year due to delays in projects for China and South Korea and intensifying competition. - FY2024-Q3WorsenedAnnual report
「In overseas markets, sales of both large and compact models fell below the previous year’s level due to delays in projects for China and other factors. Sales amounted to ¥105.150 million, down 38.1% year on year.」
In overseas new-demand development, including compact equipment, sales of large and compact models fell below the previous year’s level due to delays in projects for China and other factors. Overseas performance deteriorated from the previous quarter, when sales of compact and medium-sized models had exceeded the previous year’s level. - FY2024-Q2AdvancedAnnual report
「In overseas markets, sales of compact and medium-sized models exceeded the previous year’s level, while sales projects for large models declined. Sales amounted to ¥89.337 million, down 0.2% year on year.」
With respect to developing new demand overseas using compact and medium-sized models, sales of both models exceeded the previous year’s level. Although sales projects for large models declined, concrete progress was made in expanding compact and medium-sized models. - FY2023AdvancedAnnual report
「Our equipment has been installed at more than 2,000 facilities across Japan and more than 500 overseas. We have built a product lineup including the large “BC・ROBO-8001RFID” blood-collection tube preparation system with wireless automatic identification, the medium-sized “BC・ROBO-900,” and the compact “BC・ROBO7,” led by the development of the large model, and will continue to expand our sales channels.」
The company cites installation records at more than 2,000 domestic and 500 overseas locations, together with a lineup of large, medium-sized and compact models, establishing a concrete platform for developing new demand outside the traditional large-hospital market. - FY2022AdvancedAnnual report
「The Company has assembled a product lineup including the large BC・ROBO-8001RFID, featuring radio-frequency identification, the medium-sized BC・ROBO-900 blood collection tube preparation system, and the compact BC・ROBO7, and will seek to further expand its sales channels.」
Strong sales of small and medium-sized models drove a 14.8% year-on-year increase in sales of blood-collection tube preparation equipment and systems. New demand development at small and medium-sized facilities is making concrete progress. - FY2020AdvancedAnnual report
「Amid this business environment, we have actively worked to expand sales of our flagship blood-collection tube preparation equipment, including the compact “BC・ROBO 7” for small and medium-sized medical facilities, while promoting the adoption of high-performance models that enable safer and more accurate blood-collection operations and ensuring a stable supply of consumables and other products.」
In addition to the traditional market centered on large general hospitals, the company identifies expanding sales of the compact “BC・ROBO 7” for small and medium-sized medical facilities as a concrete initiative to develop new demand. - FY2019RestatedAnnual report
「Accordingly, we have been developing and strengthening sales of compact equipment targeting inpatient wards at large hospitals and small hospitals, rather than focusing solely on the large general hospitals targeted in the past. In addition, we have been expanding direct sales to testing laboratories that undertake clinical trial work and other services.」
The company continues to pursue new demand by strengthening the development and sales of compact equipment for small and medium-sized hospitals and expanding direct sales to testing laboratories. - FY2019-Q1AdvancedAnnual report
「Overseas sales amounted to ¥114.725 million, up 150.2% year on year, mainly due to increased sales of compact blood-collection tube preparation equipment in the Chinese market.」
Sales of the compact blood-collection tube preparation equipment targeted by the new demand-development initiative increased 150.2% year on year in the Chinese market. Concrete progress was made in overseas sales of compact equipment. - FY2018RestatedAnnual report
「Accordingly, we have been developing and strengthening sales of compact equipment targeting inpatient wards at large hospitals and small hospitals, rather than focusing solely on the large general hospitals targeted in the past. In addition, we have been expanding direct sales to testing laboratories that undertake clinical trial work and other services.」
The company continues to pursue new demand by deploying compact equipment outside large general hospitals and expanding direct sales to testing laboratories. It also indicates that securing profitability for compact products may be difficult because of the relationship between selling prices and sales costs. - FY2018-Q1AdvancedAnnual report
「Although there were some positive results, such as increased sales of compact desktop models in overseas markets, this was not enough to offset the year-on-year decline in replacement projects in Japan and overseas.」
The compact desktop models associated with the new demand-development initiative made some progress through sales growth in overseas markets. However, this was not enough to offset the decline in replacement projects. - FY2017First statedAnnual report
「Accordingly, we have been developing and strengthening sales of compact equipment targeting inpatient wards at large hospitals and small hospitals, rather than focusing solely on the large general hospitals targeted in the past. In addition, we have been expanding direct sales to testing laboratories that undertake clinical trial work and other services.」
The company identifies the deployment of compact equipment to inpatient wards and small hospitals outside the large general-hospital market, together with direct sales to testing laboratories, as new market-development initiatives.